Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 1997

View Archived Issues

Endorex licenses anticancer drug perillyl alcohol

Pfizer enters phase I trials with CP-358774

Stanford announces three studies on leg ischemia treatments

NIH announces discovery of new breast cancer gene

Glucose metabolism gene related to longevity

Palatin meets with FDA on LeuTech

Genetic Evolutionary Nutrition licenses pyruvate

Viazem approved in 10 European countries

DiagnoCure acquires NASBA technology application rights

Gene affecting neurodegeneration cloned

Kinetin clinical data to be presented at IBC symposium

Oxis granted patent application allowance for ergothioneine analogs

Salagen approved for Sjogren's syndrome in Canada

Repaglinide gets expedited review status in U.S

DPP-IV inhibition in the treatment of diabetes

Digestive tract marker evaluated in diabetic patients with gastroenteropathies

Imidazoline derivative displays potent antidiabetic effects in rats

Antidiabetic herbomineral formulation tested in Indian patients

Rapid-acting insulin analog under clinical evaluation

Boston Life Sciences completes phase III trial of Therafectin

EntreMed: Q2 1997 highlights

Merck KGaA begins development of cardioprotectant

Antimigraine agent in pharmacokinetic testing at HMR

GT35 described in patent literature by Kyowa Hakko

Fibrinogen antagonists from Yamanouchi

New antiallergy agents described by Dainippon Ink

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....